Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study.

Clicks: 431
ID: 98856
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 15 articles by views in iranian journal of basic medical sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
To investigate the efficiency of a novel series of coumarin derivatives bearing benzoheterocycle moiety as novel cholinesterase inhibitors.Different 7-hydroxycoumarin derivatives were synthesized via Pechmann or Knoevenagel condensation and conjugated to different benzoheterocycle (8-hydroxyquinoline, 2-mercaptobenzoxazole or 2-mercaptobenzimidazole) using dibromoalkanes 3a-m: Final compounds were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) by Ellman's method. Kinetic study of AChE inhibition and ligand-protein docking simulation were also carried out for the most potent compound 3b.Some of the compounds revealed potent and selective activity against AChE. Compound 3b containing the quinoline group showed the best activity with an IC value of 8.80 μM against AChE. Kinetic study of AChE inhibition revealed the mixed-type inhibition of the enzyme by compound 3b. Ligand-protein docking simulation also showed that the flexibility of the hydrophobic five carbons linker allows the quinoline ring to form π-π interaction with Trp279 in the PAS.We suggest these synthesized compounds could become potential leads for AChE inhibition and prevention of AD symptoms.
Reference Key
hirbod2017coumariniranian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hirbod, Kimia;Jalili-Baleh, Leili;Nadri, Hamid;Ebrahimi, Seyed Esmaeil Sadat;Moradi, Alireza;Pakseresht, Bahar;Foroumadi, Alireza;Shafiee, Abbas;Khoobi, Mehdi;
Journal iranian journal of basic medical sciences
Year 2017
DOI
10.22038/IJBMS.2017.8830
URL
http://ijbms.mums.ac.ir/article_8830_b043e8e9f0c14364270454802e242e00.pdf
Keywords
alzheimer’s disease acetylcholinesterase coumarin butyrylcholinesterase benzoheterocycles alzheimer’s disease acetylcholinesterase coumarinmedicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.